Dementia and Movement Disorders Market - Global Study on Treatment for Syndromes of Dementia and Movement Disorders : Asia to Witness Highest Growth by 2020
Persistence Market Research
Global Treatment for Syndromes of Dementia and Movement Disorders Market is Expected to Grow at a CAGR of 8.6% from 2014 to 2020: Persistence Market Research
Persistence Market Research
1
Dementia and Movement Disorders Market - Global Study on Treatment for Syndromes of Dementia and Movement Disorders : Asia to Witness Highest Growth by 2020
Persistence Market Research Released New Market Report “Global Market Study on Treatment for Syndromes of Dementia and Movement Disorders: Asia to Witness Highest Growth by 2020,� the global treatment for syndromes of dementia and movement disorders market was valued at USD 12,859.8 million in 2014 and is expected to grow at a CAGR of 8.6% from 2014 to 2020, to reach an estimated value of USD 21,154.8 million in 2020.
The treatment for syndromes of dementia and movement disorders market is witnessing significant growth due to increasing R&D investments in drug discovery and developments. In addition, increasing prevalence of neurodegenerative disorders and rising awareness about mental disorders are also driving the growth of the market. However, most of the drugs fail in Phase III due to lack of sufficient knowledge about the mechanisms of the brain and the unknown causes of the disease. In addition, lack of comprehensive therapeutic management, strict regulations, and time-consuming drug approval process inhibit the growth of the market. The global treatment for syndromes of dementia and movement disorders market is anticipated to grow from an estimated USD 12,859.8 million in 2014 to USD 21,154.8 million in 2020 at a CAGR of 8.6% during the forecast period.
In North America, growing aging population and rising incidence of neurodegenerative disease are driving the use of treatment for syndromes of dementia and movement disorders in the market. In addition, lack of proper medication is also fuelling the growth of treatments for syndromes of dementia and movement disorders market.
In Europe, the treatment for syndromes of dementia and movement disorders market is driven by rising incidence of mental disorder related disease and growing aging population. On the other hand, various awareness programs were launched by public and private health institutions to control dementia and movement disorders, which would increase the use of dementia and movement disorder drugs in the region.
However, in Asia the growth for treatment for syndromes of dementia and movement disorders is much higher than developed countries due to widening health insurance penetration, and large population base.
Persistence Market Research
2
Dementia and Movement Disorders Market - Global Study on Treatment for Syndromes of Dementia and Movement Disorders : Asia to Witness Highest Growth by 2020
F. Hoffmann-La Roche, Ltd., Novartis AG, Merck & Co., Inc., Sanofi S.A., Valeant Pharmaceutical International, Inc., AstraZeneca GmbH and Pfizer, Inc. are some of the major players of treatment for syndromes of dementia and movement disorders market.
Browse the full Global Market Study on Treatment for Syndromes of Dementia and Movement Disorders:
Asia
to
Witness
Highest
Growth
by
2020
report
at
http://www.persistencemarketresearch.com/market-research/treatment-syndromes-dementia-movementdisorders-market.asp
The treatment for syndromes of dementia and movement disorders market is segmented as follows: Treatment for syndromes of dementia and movement disorders market, by drugs used to treat progressive dementia •
Diseases based therapeutics under progressive dementia
•
Drugs for progressive dementia
Treatment for syndromes of dementia and movement disorders market, by drugs used to treat progressive dementia with other neurological abnormalities •
Disease based therapeutics under progressive dementia with other neurological abnormalities
•
Drugs for progressive dementia with other neurological abnormalities
Treatment for syndromes of dementia and movement disorders market, by drugs used to treat movement disorders •
Diseases based therapeutics under movement disorders
•
Drugs for movement disorders
Treatment for syndromes of dementia and movement disorders market, by geography
Persistence Market Research
3
Dementia and Movement Disorders Market - Global Study on Treatment for Syndromes of Dementia and Movement Disorders : Asia to Witness Highest Growth by 2020
•
North America
•
Europe
•
Asia
•
Rest of the World (RoW)
Market History: Globally, the treatment for syndromes of dementia and movement disorders market is witnessing significant growth due to increasing prevalence of neurodegenerative diseases. In addition, increasing R&D investment in drug delivery and development and rising awareness of mental disorders are also fueling the growth of the market. However, strict regulatory requirements and long approval time for drugs hampers growth of the global treatment for syndromes of dementia and movement disorders market. The global treatment for syndromes of dementia and movement disorders market is anticipated to grow from an estimated USD 12,859.8 million in 2014 to USD 21,154.8 million in 2020 at a CAGR of 8.6% during the forecast period. North America is the largest region for treatment for syndromes of dementia and movement disorders market and Asia is the fastest growing region. In addition, progressive dementia is the most popular and fastest growing segment in this market. Frontotemporal dementia, Alzheimer’s disease, and Lewy body dementia are some of the types of progressive dementia. The Alzheimer’s disease treatment market is anticipated to grow from an estimated USD 4,755.2 million in 2014 to USD 8,208.2 million in 2020, growing at a CAGR of 9.5% during the forecast period.
Persistence Market Research
4
Dementia and Movement Disorders Market - Global Study on Treatment for Syndromes of Dementia and Movement Disorders : Asia to Witness Highest Growth by 2020
Table of Content Chapter 1 Preface 1.1 Report Description 1.2 Research Methodology 1.3 Assumptions Chapter 2 Market Synopsis Chapter 3 Porter’s Five Forces Analysis 3.1 Bargaining Power of Suppliers 3.2 Bargaining Power of Buyers 3.3 Threat of New Entrants 3.4 Threat of Substitutes 3.5 Intensity of Rivalry Chapter 4 Industry Overview 4.1 Market Definition
Persistence Market Research
5
Dementia and Movement Disorders Market - Global Study on Treatment for Syndromes of Dementia and Movement Disorders : Asia to Witness Highest Growth by 2020 4.2 Market Drivers 4.2.1 Increasing prevalence of neurodegenerative diseases 4.2.2 Rising awareness about mental diseases 4.2.3 Increasing R&D investments in drug discovery and developments 4.3 Impact Analysis of Market Drivers 4.4 Market Restraints 4.4.1 Strict regulatory requirements and long approval time for drugs 4.4.2 Lack of comprehensive therapeutic management of dementia and movement disorders 4.5 Impact Analysis of Market Restraints 4.6 Market Trend 4.6.1 Rising number of collaborations and partnerships would lead to rise in research and discovery of dementia and movement disorder drugs Chapter 5 Global Market Size and Forecast Chapter 6 Market Size and Forecast by Drugs Used to Treat Progressive Dementia 6.1 Diseases Based Therapeutics Under Progressive Dementia 6.2 Drugs for Progressive Dementia Chapter 7 Market Size and Forecast by Drugs Used to Treat Progressive Dementia with Other Neurological Abnormalities 7.1 Diseases Based Therapeutics Under Progressive Dementia with Other Neurological Abnormalities 7.2 Drugs for Progressive Dementia Chapter 8 Market Size and Forecast by Drugs Used to Treat Movement Disorder Syndrome 8.1 Diseases Based Therapeutics Under Movement Disorder Syndrome 8.2 Drugs for Movement Disorder Syndrome Chapter 9 Market Size and Forecast by Geography 9.1 North America 9.2 Europe 9.3 Asia
Persistence Market Research
6
Dementia and Movement Disorders Market - Global Study on Treatment for Syndromes of Dementia and Movement Disorders : Asia to Witness Highest Growth by 2020
Chapter 10 Competitive Scenario 10.1 Competitive Benchmarking Chapter 11 Company Profiles 11.1 F. Hoffmann-La Roche, Ltd. 11.1.1 Company overview 11.1.2 Products and services 11.1.3 Financial performance 11.1.4 Key developments 11.2 Baxter 11.2.1 Company overview 11.2.2 Products and services 11.2.3 Financial performance 11.2.4 Key development 11.3 Novartis AG 11.3.1 Company overview 11.3.2 Products and services 11.3.3 Financial performance 11.3.4 Key developments 11.4 Merck & Co., Inc. 11.4.1 Company overview 11.4.2 Products and services 11.4.3 Financial performance 11.4.4 Key developments 11.5 Sanofi 11.5.1 Company overview 11.5.2 Products and services 11.5.3 Financial performance 11.5.4 Key developments 11.6 Pfizer, Inc. 11.6.1 Company overview 11.6.2 Products and services 11.6.3 Financial performance
Persistence Market Research
7
Dementia and Movement Disorders Market - Global Study on Treatment for Syndromes of Dementia and Movement Disorders : Asia to Witness Highest Growth by 2020 11.6.4 Key developments 11.7 Valeant Pharmaceuticals International, Inc. 11.7.1 Company overviews 11.7.2 Products and services 11.7.3 Financial performance 11.7.4 Key developments 11.8 AstraZeneca GmbH 11.8.1 Company overview 11.8.2 Products and services 11.8.3 Financial performance 11.8.4 Key developments 11.9 Abbott Laboratories, Inc. 11.9.1 Company overview 11.9.2 Products and services 11.9.3 Financial performance 11.9.4 Key developments 11.10 Bristol-Myers Squibb Company 11.10.1 Company overview 11.10.2 Products and services 11.10.3 Financial performance 11.10.4 Key developments List of Tables TABLE 1 Market snapshot: Treatment for syndromes of dementia and movement disorders market, 2014 and 2020 TABLE 2 Drivers for global treatment for syndrome of dementia and movement disorders market: Impact analysis TABLE 3 Estimated average timelines for clinical trial approval in various countries TABLE 4 Restraints for global treatment for syndromes of dementia and movement disorders market: Impact analysis TABLE 5 Major collaborations and partnerships by dementia and movement disorder treatment companies (2011 – 2013)
Persistence Market Research
8
Dementia and Movement Disorders Market - Global Study on Treatment for Syndromes of Dementia and Movement Disorders : Asia to Witness Highest Growth by 2020 TABLE 6 Global treatments for syndromes of dementia and movement disorders market size, by region, 2010 – 2013 (USD million) TABLE 7 Global treatments for syndromes of dementia and movement disorders market size, by region, 2014 – 2020 (USD million) TABLE 8 Global treatments for syndromes of dementia and movement disorders market size, by segment, 2010 – 2013 (USD million) TABLE 9 Global treatments for syndromes of dementia and movement disorders market size, by segment, 2014 – 2020 (USD million) TABLE 10 Global progressive dementia therapeutic market size, by disease, 2010 – 2013 (USD million) TABLE 11 Global progressive dementia therapeutic market size, by disease, 2014 – 2020 (USD million) TABLE 12 Global progressive dementia market size, by drug category, 2010 – 2013 (USD million) TABLE 13 Global progressive dementia market size, by drug category, 2014 – 2020 (USD million) TABLE 14 Global progressive dementia with other neurological abnormalities therapeutics market size, by disease, 2010 – 2013 (USD million) TABLE 15 Global progressive dementia with other neurological abnormalities therapeutic market size, by disease, 2014 – 2020 (USD million) TABLE 16 Global progressive dementia with other neurological abnormalities market size, by drug category, 2010 – 2013 (USD million) TABLE 17 Global progressive dementia with other neurological abnormalities market size, by drug category, 2014 – 2020 (USD million) TABLE 18 Global movement disorder syndrome therapeutics market size, by disease, 2010 – 2013 (USD million) TABLE 19 Global movement disorder syndrome therapeutics market size, by disease, 2014 – 2020 (USD million) TABLE 20 Global movement disorders market size, by drug category, 2010 – 2013 (USD million) TABLE 21 Global movement disorder market size, by drug category, 2014 – 2020 (USD million) TABLE 22 The North American treatment for syndromes of dementia and movement disorders market size, by country, 2010 – 2013 (USD million) TABLE 23 The North American treatment for syndromes of dementia and movement disorders market size, by country, 2014 – 2020 (USD million) TABLE 24 The North American treatments for syndromes of dementia and movement disorders market size, by segment, 2010 – 2013 (USD million) TABLE 25 The North American treatments for syndromes of dementia and movement disorders market size, by segment, 2014 – 2020 (USD million)
Persistence Market Research
9
Dementia and Movement Disorders Market - Global Study on Treatment for Syndromes of Dementia and Movement Disorders : Asia to Witness Highest Growth by 2020 TABLE 26 The European treatment for syndromes of dementia and movement disorders market size, by country, 2010 – 2013 (USD million) TABLE 27 The European treatment for syndromes of dementia and movement disorders market size, by country, 2014 – 2020 (USD million) TABLE 28 The European treatments for syndromes of dementia and movement disorders market size, by segment, 2010 – 2013 (USD million) TABLE 29 The European treatments for syndromes of dementia and movement disorders market size, by segment, 2014 – 2020 (USD million) TABLE 30 The Asian treatment for syndromes of dementia and movement disorders market size, by country, 2010 – 2013 (USD million) TABLE 31 The Asian treatment for syndromes of dementia and movement disorders market size, by country, 2014 – 2020 (USD million) TABLE 32 The Asian treatments for syndromes of dementia and movement disorders market size, by segment, 2010 – 2013 (USD million) TABLE 33 The Asian treatments for syndromes of dementia and movement disorders market size, by segment, 2014 – 2020 (USD million) TABLE 34 F. Hoffmann-La Roche, Ltd.’s product categories TABLE 35 Baxter’s product categories TABLE 36 Novartis AG’s product categories TABLE 37 Merck & Co., Inc.’s product categories TABLE 38 Sanofi’s product categories TABLE 39 Pfizer, Inc.’s product categories TABLE 40 Valeant Pharmaceuticals International, Inc.’s product categories TABLE 41 AstraZeneca GmbH’s product categories TABLE 42 Abbott Laboratories, Inc.’s product categories TABLE 43 Bristol-Myers Squibb Company’s product categories List of Figures FIG. 1 Treatment for syndromes of dementia and movement disorders market: Porter’s five forces analysis FIG. 2 Types of dementia and movement disorders 18 FIG. 3 Global treatments for syndromes of dementia and movement disorders market share, by region, by value, 2013
Persistence Market Research
10
Dementia and Movement Disorders Market - Global Study on Treatment for Syndromes of Dementia and Movement Disorders : Asia to Witness Highest Growth by 2020 FIG. 4 Global treatments for syndromes of dementia and movement disorders market share, by segment, by value, 2013 FIG. 5 Global progressive dementia therapeutic market share, by disease, by value, 2013 FIG. 6 Global progressive dementia market share, by drug category, by value, 2013 FIG. 7 Global progressive dementia with other neurological abnormalities therapeutics market share, by disease, by value, 2013 FIG. 8 Global progressive dementia with other neurological abnormalities market share, by drug category, by value, 2013 FIG. 9 Global movement disorder syndrome therapeutics market share, by disease, by value, 2013 FIG. 10 Global movement disorder syndrome market share, by drug category, by value, 2013 FIG. 11 The North American treatment for syndromes of dementia and movement disorders market share, by country, by value, 2013 FIG. 12 The North American treatments for syndromes of dementia and movement disorders market share, by segment, by value, 2013 FIG. 13 The European treatment for syndromes of dementia and movement disorders market share, by country, by value, 2013 FIG. 14 The European treatments for syndromes of dementia and movement disorders market share, by segment, by value, 2013 FIG. 15 The Asian treatment for syndromes of dementia and movement disorders market share, by country, by value, 2013 FIG. 16 The Asian treatments for syndromes of dementia and movement disorders market share, by segment, by value, 2013 FIG. 17 Competitive landscape of treatment providers for syndromes of dementia and movement disorders, 2013 FIG. 18 F. Hoffmann-La Roche, Ltd.’s sales and net income, 2011 – 2013 (USD million) FIG. 19 Baxter’s net sales and net income, 2011 – 2013 (USD million) FIG. 20 Novartis AG’s net sales and net income, 2011 – 2013 (USD million) FIG. 21 Merck & Co., Inc.’s sales and net income, 2011 – 2013 (USD million) FIG. 22 Sanofi net sales and net income, 2011 – 2013 (USD million) FIG. 23 Pfizer, Inc.’s revenue and net income, 2011 – 2013 (USD million) FIG. 24 Valeant Pharmaceuticals International, Inc.’s revenues and net income/loss, 2011 – 2013 (USD million) FIG. 25 AstraZeneca GmbH’s revenues and profit, 2011 – 2013 (USD million) FIG. 26 Abbott Laboratories’ net sales and net earnings, 2011 – 2013 (USD million)
Persistence Market Research
11
Dementia and Movement Disorders Market - Global Study on Treatment for Syndromes of Dementia and Movement Disorders : Asia to Witness Highest Growth by 2020 FIG. 27 Bristol-Myers Squibb’s revenue and net earnings, 2011 – 2013 (USD million)
About Us: Persistence Market Research is a global market research firm specializing- syndicated research, custom research, and consulting services
At Persistence Market Research (PMR), we are in the business of accelerating your business. As a fullservice market research firm, we stand committed to bringing more accuracy and speed to your business decisions. From ready-to-purchase market research reports to customized global research solutions, our engagement models are highly flexible without compromising on our deep-seated research values. Briefly stated, our mission is to give you access to forecasts and trends analyses that put you on the path to profitability.
PMR’s Services Go Beyond Gleaning Data
Most enterprises believe that IT and databases are enough to make an accurate decision. While we do not dispute that, consider this: How long does it take to make an accurate and strategic million-dollar decision? We strive to deliver both even with demanding deadlines.
Contact Us: Addie Thomes 305 Broadway, 7th Floor, New York City, NY 10007, United States. Tel: No. +1-646-568-77 USA/Canada Toll Free Number.1-800-961-0353 E-mail: Sales@persistencemarketresearch.com web: http://www.persistencemarketresearch.com/
Persistence Market Research
12